Journal
CELL METABOLISM
Volume 20, Issue 5, Pages 703-705Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2014.10.017
Keywords
-
Categories
Funding
- NCI NIH HHS [P01 CA077839] Funding Source: Medline
Ask authors/readers for more resources
A substantive literature has accumulated implicating sphingolipids, in particular ceramides, as mediators of insulin resistance in metabolic syndrome. Thanks to recent technical advances in mouse genetics and lipidomics, two independent laboratories identify the same sphingolipid, C16: 0-ceramide, as principal mediator of obesity-related insulin resistance (Turpin et al., 2014; Raichur et al., 2014).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
